MedPath

CPC in Adult Refractory Glaucoma

Not Applicable
Conditions
Refractory Glaucoma
Interventions
Procedure: Diode Laser Cyclophotocoagulation
Registration Number
NCT04921098
Lead Sponsor
Sohag University
Brief Summary

The purpose of this study is to assess the relative effectiveness and safety of diode laser cyclophotocoagulation procedure to reduce IOP and relieve pain in adult patients with refractory glaucoma.

Detailed Description

A hospital -based, prospective interventional non comparative case series study.This study will be conducted on patients with refractory glaucoma whose ages are 18 years and older.They will be subjected to Transscleral Diode Laser Cyclophotocoagulation.

Postoperative evaluation will be scheduled for the first day postoperative, then 1 week later and then at 1st, 3rd, month postoperative.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Inclusion Criteria:

    1. Patients with refractory glaucoma aging 18 years and older.
    2. Both sexes are included.
    3. Patients Capable of giving informed consent.
    4. Pseudophkic glaucoma.
    5. Aphakic glaucoma.
    6. Silicon oil induced glaucoma.
    7. Neovascular glaucoma.
    8. Inflammatory glaucoma.
Exclusion Criteria
  1. Patients <18 years of age.
  2. Patients controlled on regular antiglaucomatous therapy.
  3. Patients who cannot do regular follow up visits.
  4. Diffuse scleral staphyloma at the site of CPC.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Refractory glaucomaDiode Laser Cyclophotocoagulation-
Primary Outcome Measures
NameTimeMethod
change in intraocular pressureFirst day postoperative and 1 week

IOP measuring using Goldmann applanation tonometer.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath